scholarly journals 1401: A Phase I/II Study of a Chimeric Antibody Against Interleukin-6 (CNTO 328) in Subjects with Metastatic Renal Cell Carcinoma

2005 ◽  
Vol 173 (4S) ◽  
pp. 380-380
Author(s):  
Peter F. Mulders ◽  
Frans M.J. Debruyne ◽  
Kim de Weijer ◽  
Jean-Francois Rossi ◽  
Sheila Patil ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Interleukin 6 ◽  
Renal Cell ◽  
Chimeric Antibody

scholarly journals A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

2014 ◽  
Vol 37 (3) ◽  
pp. 180-186 ◽  
Author(s):  
Paul Monk ◽  
Elaine Lam ◽  
Amir Mortazavi ◽  
Kari Kendra ◽  
Gregory B. Lesinski ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Interleukin 2 ◽  
High Dose

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study

2017 ◽  
Vol 85 ◽  
pp. 39-48 ◽  
Author(s):  
Alain Ravaud ◽  
Carlos Gomez-Roca ◽  
Marie-Quitterie Picat ◽  
Laurence Digue ◽  
Christine Chevreau ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Solid Tumours

scholarly journals Phase I Study of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma (Mrcc)

2014 ◽  
Vol 25 ◽  
pp. iv361 ◽  
Author(s):  
H. Hammers ◽  
E.R. Plimack ◽  
J.R. Infante ◽  
M. Ernstoff ◽  
B.I. Rini ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study

scholarly journals A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinoma

1995 ◽  
Vol 6 (9) ◽  
pp. 911-914 ◽  
Author(s):  
R. Amato ◽  
C. Meyers ◽  
J. Ellerhorst ◽  
L. Finn ◽  
R. Kilbourn ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
High Dose

scholarly journals A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma

2019 ◽  
Vol 25 (2) ◽  
pp. 121 ◽  
Author(s):  
Andrew W. Hahn ◽  
Charles Drake ◽  
Samuel R. Denmeade ◽  
Yousef Zakharia ◽  
Benjamin L. Maughan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study

scholarly journals Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma

2009 ◽  
Vol 7 (1) ◽  
pp. 28-33 ◽  
Author(s):  
Robert J. Motzer ◽  
Gary Hudes ◽  
George Wilding ◽  
Lawrence H. Schwartz ◽  
Subramanian Hariharan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Interferon Α ◽  
Sunitinib Malate
Sign in / Sign up

Export Citation Format

Share Document